Sosei Group Corporation has announced that Dr. Fiona Marshall has resigned from her position as Executive Vice President and Chief Scientific Officer to assume a senior role outside the Company. Sosei’s R&D activities will continue under the leadership of Dr. Malcolm Weir, co-founder and Chief Executive Officer of Heptares, and Executive Vice President and Chief R&D Officer of Sosei. Separately, and reflecting the progress of Sosei’s proprietary pipeline of drug development candidates, Dr. Tim Tasker is promoted to the Executive management team of Sosei as an Executive Vice President and Chief Medical Officer (CMO).
